Navigation Links
Uptake Medical Announces Scott Huennekens Elected to Board of Directors
Date:3/1/2011

IRVINE, Calif., March 1, 2011 /PRNewswire/ -- Uptake Medical® Corp., a developer of medical technologies for the non-surgical treatment of lung diseases including emphysema, announced today that Scott Huennekens, President and CEO of Volcano Corporation, (Nasdaq: VOLC) has joined the company's Board of Directors.

Mr. Huennekens has served as President, CEO and Director of Volcano since April 2002. He led the company from a pre-revenue start-up to its IPO in 2006 and its current market-leading position through consistent growth by utilizing innovative technologies, strong clinical science and focused expansion throughout the global markets. He's been successful in leading both private and public traded companies. From 2000-2002, he headed Digirad Corporation, a medical device imaging company. From 1993-1997 he was at Baxter Healthcare's Cardiovascular Group (Edwards Lifesciences). Mr. Huennekens is a member of the Board of Directors of Medical Device Manufacturers Association (MDMA) and BIOCOM. He received his B.S. in Business Administration from the University of Southern California and an M.B.A. from Harvard Business School.

King Nelson, President and CEO of Uptake Medical said, "We're thrilled to have Scott join our Board of Directors at this important time as we transition from development to commercialization of our InterVapor™ system. He's a very well respected businessman, innovator and strategic thinker, and is experienced in global business operations. He has an incredible understanding of the trends in the medical device marketplace and the clinicians' mindset."

He also added, "Scott is one of the true opinion leaders in the medical device area and we're excited to have him join the company. He'll be very helpful as Uptake Medical moves toward early commercialization outside the U.S. and initiates pivotal U.S. clinical trial activities in 2011. He'll provide critical guidance as Uptake continues to build upon the industry's best clinical results for the large number of emphysema sufferers around the world. Scott has demonstrated success in helping combine innovative technology and science in creative ways to bring treatment solutions to patients."

Mr. Huennekens stated, "I look forward to working with the Uptake Medical team to bring their innovative InterVapor system to patients suffering from emphysema throughout the world. The clinical results to date are very encouraging and offer great promise. I'm excited about Uptake's prospects."

About Uptake Medical

Uptake Medical® Corp. is a developer of medical technologies for the treatment of lung diseases including emphysema. The core InterVapor technology is a simple, minimally invasive, non-implant interventional pulmonary approach designed to measurably improve lung function and patient quality of life. Emphysema afflicts over 4.5 million people in the United States. It is a form of chronic obstructive pulmonary disease (COPD), primarily caused by smoking, and is a major cause of chronic disease and death throughout the world. It accounts for over $40 billion in healthcare costs. More information and a list of participating clinical trial sites can be found at http://www.uptakemedical.com/.


'/>"/>
SOURCE Uptake Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
2. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
3. Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019
4. Uptake Medical Names J.C. MacRae as Chief Financial Officer
5. The Harley Medical Group Sees an Uptake in Surgery Bookings for Christmas
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Globus Medical Raises $110 Million in Series E Financing Round
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. Boston University Biomedical Engineers Find Chink in Bacterias Armor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
Breaking Medicine News(10 mins):